On the occasion of its 80th anniversary, Bionorica SE has launched a Global Research Initiative, which will focus in particular on the scientific exploration of new ideas for improving health with medicinal plants and plant extracts. Bionorica is very interested in innovative and practice-oriented research in the area of phytomedicine that will improve the patients’ quality of life or protect human health.
Bionorica SE, a leading company in the area of phytomedicines, markets products with proven efficacy, safety and quality in 50 countries worldwide. Products include the well-known Sinupret® and Bronchipret®. Bionorica sees the steadily increasing interest in phytomedicines for supporting health and realizes that proven efficacy, safety, quality and research-proven phytomedicines are finding their place in evidence-based medicine.
To encourage such research, The Global Research Initiative consists of 20 Research Awards amounting to 50,000 euros each for a period of one year. An international jury of renowned experts, selected by Bionorica SE, will evaluate the applications/projects received and will nominate the 20 award winners.
The research awards are designed to be flexible enough to support a very wide range of research needs. The ultimate aims of all research projects within Bionorica’s Global Research Initiative, however, is to generate measurable and testable data, gradually adding to the accumulation of human knowledge about plant based medicines and thus improving the health and/or protecting the well-being of healthy people.
Applications are available and submissions will be accepted through Oct. 15, 2013. The review process will be end Nov. 30, 2013.
According to Pierce Sioussat, president of Bioforce USA, “we are very proud to be affiliated with Bionorica and share the goal of improving health through science backed botanical products. Researchers may contact us for information on submitting an application.”